FIELD: medicine.
SUBSTANCE: invention refers to therapy, and concerns treating infectious diseases. To do so, therapeutic agent containing activated-potentiated form of human gamma-interferon antibodies in combination with activated-potentiated form of anti-CD4 T-lymphocytes and activated-potentiated form of histamine antibodies is introduced.
EFFECT: this provides effective treatment of infectious, including viral diseases by synergetic action of ingredients of drug.
14 cl, 2 dwg, 8 tbl, 5 ex
Authors
Dates
2016-08-27—Published
2014-10-02—Filed